Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1994 1
2000 1
2001 2
2002 1
2003 1
2010 2
2011 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
Peták I, Houghton JA. Peták I, et al. Pathol Oncol Res. 2001;7(2):95-106. doi: 10.1007/BF03032574. Pathol Oncol Res. 2001. PMID: 11458271 Free article. Review.
Hedgehog signaling drives cellular survival in human colon carcinoma cells.
Mazumdar T, DeVecchio J, Shi T, Jones J, Agyeman A, Houghton JA. Mazumdar T, et al. Cancer Res. 2011 Feb 1;71(3):1092-102. doi: 10.1158/0008-5472.CAN-10-2315. Epub 2010 Dec 6. Cancer Res. 2011. PMID: 21135115 Free PMC article.
cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells.
Shi T, Mazumdar T, Devecchio J, Duan ZH, Agyeman A, Aziz M, Houghton JA. Shi T, et al. PLoS One. 2010 Oct 1;5(10):e13054. doi: 10.1371/journal.pone.0013054. PLoS One. 2010. PMID: 20957031 Free PMC article.
Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells.
Mazumdar T, Devecchio J, Agyeman A, Shi T, Houghton JA. Mazumdar T, et al. Cancer Res. 2011 Sep 1;71(17):5904-14. doi: 10.1158/0008-5472.CAN-10-4173. Epub 2011 Jul 11. Cancer Res. 2011. PMID: 21747117 Free PMC article.
Developing novel and highly effective new therapeutic strategies for treatment of colorectal cancer: where do we go from here?
Houghton JA. Houghton JA. Curr Opin Investig Drugs. 2001 May;2(5):674-6. Curr Opin Investig Drugs. 2001. PMID: 11569946 Review. No abstract available.
Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J, Petak I, Szucs KS, Nagy K, Tillman DM, Houghton JA. Geller J, et al. Clin Cancer Res. 2003 Dec 15;9(17):6504-15. Clin Cancer Res. 2003. PMID: 14695155 Free article.
Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
Schwartzberg LS, Petak I, Stewart C, Turner PK, Ashley J, Tillman DM, Douglas L, Tan M, Billups C, Mihalik R, Weir A, Tauer K, Shope S, Houghton JA. Schwartzberg LS, et al. Clin Cancer Res. 2002 Aug;8(8):2488-98. Clin Cancer Res. 2002. PMID: 12171874 Free article. Clinical Trial.
p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I, Tillman DM, Houghton JA. Petak I, et al. Clin Cancer Res. 2000 Nov;6(11):4432-41. Clin Cancer Res. 2000. PMID: 11106264 Free article.
Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors.
Pratt CB, Meyer WH, Howlett N, Douglass EC, Bowman LC, Poe D, Mounce K, Kun LE, Houghton JA. Pratt CB, et al. Cancer. 1994 Nov 1;74(9):2593-8. doi: 10.1002/1097-0142(19941101)74:9<2593::aid-cncr2820740930>;2-c. Cancer. 1994. PMID: 7923016 Clinical Trial.
Characterization of the pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in xenografts of human colon adenocarcinoma.
Houghton JA, Williams LG, Radparvar S, Houghton PJ. Houghton JA, et al. Cancer Res. 1988 Jun 1;48(11):3062-9. Cancer Res. 1988. PMID: 3365696 Free article.